» Articles » PMID: 24512718

Synergistic Enhancement of NK Cell-mediated Cytotoxicity by Combination of Histone Deacetylase Inhibitor and Ionizing Radiation

Overview
Journal Radiat Oncol
Publisher Biomed Central
Specialties Oncology
Radiology
Date 2014 Feb 12
PMID 24512718
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The overexpression of histone deacetylase (HDAC) and a subsequent decrease in the acetylation levels of nuclear histones are frequently observed in cancer cells. Generally it was accepted that the deacetylation of histones suppressed expression of the attached genes. Therefore, it has been suggested that HDAC might contribute to the survival of cancer cells by altering the NKG2D ligands transcripts. By the way, the translational regulation of NKG2D ligands remains unclear in cancer cells. It appears the modulation of this unclear mechanism could enhance NKG2D ligand expressions and the susceptibility of cancer cells to NK cells. Previously, it was reported that irradiation can increase the surface expressions of NKG2D ligands on several cancer cell types without increasing the levels of NKG2D ligand transcripts via ataxia telangiectasia mutated and ataxia telangiectasia and Rad3 related (ATM-ATR) pathway, and suggested that radiation therapy might be used to increase the translation of NKG2D ligands.

Methods: Two NSCLC cell lines, that is, A549 and NCI-H23 cells, were used to investigate the combined effects of ionizing radiation and HDAC inhibitors on the expressions of five NKG2D ligands. The mRNA expressions of the NKG2D ligands were quantitated by multiplex reverse transcription-PCR. Surface protein expressions were measured by flow cytometry, and the susceptibilities of cancer cells to NK cells were assayed by time-resolved fluorometry using the DELFIA® EuTDA cytotoxicity kit and by flow cytometry.

Results: The expressions of NKG2D ligands were found to be regulated at the transcription and translation levels. Ionizing radiation and HDAC inhibitors in combination synergistically increased the expressions of NKG2D ligands. Furthermore, treatment with ATM-ATR inhibitors efficiently blocked the increased translations of NKG2D ligands induced by ionizing radiation but did not block the increased ligand translations induced by HDAC inhibitors. The study confirms that increased NKG2D ligand levels by ionizing radiation and HDAC inhibitors could synergistically enhance the susceptibilities of cancer cells to NK-92 cells.

Conclusions: This study suggests that the expressions of NKG2D ligands are regulated in a complex manner at the multilevel of gene expression, and that their expressions can be induced by combinatorial treatments in lung cancer cells.

Citing Articles

Epigenetic regulation of NKG2D ligand and the rise of NK cell-based immunotherapy for cancer treatment.

Kumar R, Gupta R Front Oncol. 2024; 14:1456631.

PMID: 39161385 PMC: 11330816. DOI: 10.3389/fonc.2024.1456631.


Intensified NK cell therapy in combination with low-dose chemoradiotherapy against human colorectal cancer.

Nguyen H, Bae W, Park M, Chung I, Nam T, Jeong J Cancer Immunol Immunother. 2023; 72(12):4089-4102.

PMID: 37801126 PMC: 10992501. DOI: 10.1007/s00262-023-03545-w.


HDAC-an important target for improving tumor radiotherapy resistance.

Ling R, Wang J, Fang Y, Yu Y, Su Y, Sun W Front Oncol. 2023; 13:1193637.

PMID: 37503317 PMC: 10368992. DOI: 10.3389/fonc.2023.1193637.


Immunologically relevant effects of radiation therapy on the tumor microenvironment.

Galassi C, Klapp V, Formenti S, Demaria S, Galluzzi L Essays Biochem. 2023; 67(6):979-989.

PMID: 37199227 PMC: 10543618. DOI: 10.1042/EBC20220248.


Dying of Stress: Chemotherapy, Radiotherapy, and Small-Molecule Inhibitors in Immunogenic Cell Death and Immunogenic Modulation.

Fabian K, Kowalczyk J, Reynolds S, Hodge J Cells. 2022; 11(23).

PMID: 36497086 PMC: 9737874. DOI: 10.3390/cells11233826.


References
1.
Skov S, Pedersen M, Andresen L, Straten P, Woetmann A, Odum N . Cancer cells become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to glycogen synthase kinase-3-dependent expression of MHC class I-related chain A and B. Cancer Res. 2005; 65(23):11136-45. DOI: 10.1158/0008-5472.CAN-05-0599. View

2.
Baylin S, Esteller M, Rountree M, Bachman K, Schuebel K, Herman J . Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet. 2001; 10(7):687-92. DOI: 10.1093/hmg/10.7.687. View

3.
Butler J, Moore M, Presnell S, Chan H, Chalupny N, Lutz C . Proteasome regulation of ULBP1 transcription. J Immunol. 2009; 182(10):6600-9. PMC: 2748925. DOI: 10.4049/jimmunol.0801214. View

4.
Champsaur M, Lanier L . Effect of NKG2D ligand expression on host immune responses. Immunol Rev. 2010; 235(1):267-85. PMC: 2885032. DOI: 10.1111/j.0105-2896.2010.00893.x. View

5.
Gasser S, Orsulic S, Brown E, Raulet D . The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature. 2005; 436(7054):1186-90. PMC: 1352168. DOI: 10.1038/nature03884. View